Brii Bioscience Ltd (BRIBF) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, ladies and gentlemen, and thank you for standing by. And welcome to BRIE Biosciences Limited 2021 Annual Results and Business Update Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. It is now my pleasure to turn the call over to Ms. Chris Fang, Director of Investor Relations. Please go ahead, Chris. Thank you, Operator. Welcome to GreenBowl's 2021 Annual Results and Business Update Conference Call. Our annual results announcements can be found on the Investor Relations section of our company website. Joining me today on the call from GreenBowl's senior management team are Dr. Z. Hong, our co-founder, chairman, and the chief executive officer, Mr. Rogers Luo, our president and general manager of Greater China, Dr. Lee Yin, our chief medical officer, and Dr. Ang Kong Lee, our chief financial and strategy officer. Dr. Hong will provide a high-level overview of our key programs, company strategy, and future development plan, followed by Mr. Law, who will summarize further details about our HPV and COVID-19 programs, and our overarching prioritizations of R&D and commercial efforts in China. Dr. Yan will provide updates on central neuroscience programs as a priority for the UIC. Dr. Li will then provide a brief summary of our full financial results and corporate strategy, including business development plan. After the management team's presentation, we will open the Q&A session to take questions. Before we start, we would like to remind you that for today's discussion may contain forward-looking statements, which involve a number of risks and uncertainties. Actual results and outcomes may differ materially from those mentioned in today's annou...